Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cidara Therapeutics stock
Learn how to easily invest in Cidara Therapeutics stock.
Cidara Therapeutics Inc is a biotechnology business based in the US. Cidara Therapeutics shares (CDTX) are listed on the NASDAQ and all prices are listed in US Dollars. Cidara Therapeutics employs 89 staff and has a trailing 12-month revenue of around $27.6 million.
How to buy shares in Cidara Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CDTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cidara Therapeutics stock price (NASDAQ: CDTX)Use our graph to track the performance of CDTX stocks over time.
Cidara Therapeutics shares at a glance
|Latest market close||$0.65|
|52-week range||$0.40 - $2.39|
|50-day moving average||$0.71|
|200-day moving average||$0.78|
|Wall St. target price||$5.83|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.74|
Buy Cidara Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cidara Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cidara Therapeutics price performance over time
|1 week (2022-09-23)||-2.98%|
|1 month (2022-09-01)||-4.82%|
|3 months (2022-07-01)||44.79%|
|6 months (2022-03-30)||-22.16%|
|1 year (2021-10-01)||-70.18%|
|2 years (2020-10-01)||-77.35%|
|3 years (2019-10-01)||1.935|
|5 years (2017-09-29)||8.1|
Cidara Therapeutics financials
|Revenue TTM||$27.6 million|
|Gross profit TTM||$-23,515,000|
|Return on assets TTM||-80.11%|
|Return on equity TTM||-1693.56%|
|Market capitalisation||$47 million|
TTM: trailing 12 months
Cidara Therapeutics share dividends
We're not expecting Cidara Therapeutics to pay a dividend over the next 12 months.
Cidara Therapeutics share price volatility
Over the last 12 months, Cidara Therapeutics's shares have ranged in value from as little as $0.4 up to $2.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cidara Therapeutics's is 1.5449. This would suggest that Cidara Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cidara Therapeutics overview
Cidara Therapeutics, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014.
Cidara Therapeutics in the news
Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Cidara Therapeutics Announces Initiation of Phase 2a Human Viral Challenge Trial to Evaluate CD388 for Universal Prevention of Influenza
Cidara Therapeutics to Present at the 24th Annual H.C. Wainwright Global Investment Conference
Frequently asked questionsWhat percentage of Cidara Therapeutics is owned by insiders or institutions?
Currently 11.673% of Cidara Therapeutics shares are held by insiders and 40.537% by institutions. How many people work for Cidara Therapeutics?
Latest data suggests 89 work at Cidara Therapeutics. When does the fiscal year end for Cidara Therapeutics?
Cidara Therapeutics's fiscal year ends in December. Where is Cidara Therapeutics based?
Cidara Therapeutics's address is: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121 What is Cidara Therapeutics's ISIN number?
Cidara Therapeutics's international securities identification number is: US1717571079 What is Cidara Therapeutics's CUSIP number?
Cidara Therapeutics's Committee on Uniform Securities Identification Procedures number is: 171757107
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert